• Lactate, OXPHOS, and Peripheral Nerve Regeneration

  2026-09-18

  A 2026 study identifies lactate as a concentration-dependent regulator of macrophage behavior after sciatic nerve injury. Its findings connect low-dose lactate with oxidative phosphorylation, Cebpb expression, M2-associated repair programs, and improved nerve regeneration, while excessive lactate produces mitochondrial stress rather than additional benefit.

• Notch Inhibition Sensitizes TNBC to Checkpoint Blockade

  2026-09-18

  Shen and colleagues show that aberrant Notch activity reshapes the triple-negative breast cancer immune microenvironment by promoting cytokine programs that recruit tumor-associated macrophages. Their study identifies sequential Notch-pathway suppression and immune checkpoint blockade as a strategy that increases cytotoxic T-cell activity and markedly limits lung metastasis in experimental models.

• Tubastatin A Limits Myocardial Damage After Cardiac Arrest

  2026-09-17

  A 2025 porcine study examined whether Tubastatin A could reduce myocardial injury after cardiac arrest and cardiopulmonary resuscitation. Treatment was associated with better post-resuscitation cardiac function, lower injury biomarkers, and reduced molecular signals linked to GSDME-mediated pyroptosis and MLKL-mediated necroptosis, although the findings remain mechanistic and preliminary.

• USP25 Variants and Genetic Generalized Epilepsy

  2026-09-17

  This study links heterozygous USP25 variants to genetic generalized epilepsy through integrated human genetics, mouse seizure modeling, and cellular and neuronal functional assays. Its central contribution is the demonstration that USP25 disruption may promote epileptogenesis through distinct loss-of-function and variant-specific gain-of-function mechanisms, while also illustrating the limits of treating all variants as biologically equivalent.

• Halazone Workflows for Water and Nerve Assays

  2026-09-16

  Halazone supports two distinct research workflows: oxidation-based water disinfection testing and mechanistic sodium-current assays in myelinated nerve fibers. This guide connects concentration control, fresh-solution handling, voltage-clamp design, and troubleshooting without treating a research reagent as a substitute for a regulated drinking-water product.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Assay Reliability

  2026-09-16

  This scenario-driven guide shows how EZ Cap™ Mouse IL-12 mRNA (m1Ψ), SKU R1058, can support controlled viability, proliferation, cytotoxicity, and immune-response experiments. It connects formulation, handling, assay controls, and emerging extrahepatic delivery evidence without overstating product-specific performance.

• Methicillin Sodium Salt: Assay Logic & MoA

  2026-09-15

  Methicillin sodium salt is a mechanistic probe for PBP-dependent inhibition in MSSA research. This guide connects its resistance-aware assay design with high-throughput target-deconvolution principles, helping researchers distinguish a true cell-wall phenotype from nonspecific growth inhibition.

• Calpain Inhibitor I, ALLN: Practical Guide

  2026-09-15

  Calpain Inhibitor I, ALLN (SKU A2602) is a DMSO-soluble cysteine-protease inhibitor for probing calpain and cathepsin contributions to apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used as a mechanistic research tool with vehicle, viability, and orthogonal protease controls, not as a diagnostic, therapeutic, or calpain-exclusive reagent.

• EZ Cap™ mCherry mRNA: Evidence and Workflow

  2026-09-14

  EZ Cap™ mCherry mRNA is a Cap 1-modified red fluorescent protein mRNA designed for reproducible fluorescent protein expression. Its 5mCTP and ψUTP nucleotides, approximately 100-nucleotide poly(A) tail, and defined citrate formulation support mRNA stability and translation enhancement while reducing innate immune stimulation.

• EdU Imaging Kits (HF594) for Treg Proliferation

  2026-09-14

  EdU Imaging Kits (HF594) combine 5-ethynyl-2’-deoxyuridine labeling with HyperFluor™ 594 click chemistry for sensitive S-phase measurements in microscopy and flow cytometry. The workflow is particularly useful for separating Treg identity, differentiation state, and actual proliferative activity in immunometabolic and drug-response studies.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-13

  Carbenoxolone disodium (SKU A8389) is an 11β-hydroxysteroid dehydrogenase inhibitor for exploratory studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is suitable for controlled cell and tissue workflows, but should not be treated as a selective target-validation reagent or an in vivo efficacy treatment when off-target effects and electrolyte-related physiology cannot be separated.

• Lanabecestat: Designing BACE1 Assays

  2026-09-12

  Lanabecestat (AZD3293) is a potent, brain-penetrant BACE1 inhibitor for Alzheimer’s disease research. This guide presents an assay-design framework that connects amyloid-beta reduction with synaptic-function readouts for more informative preclinical studies.

• Lapatinib (GW572016) Research Workflows

  2026-09-11

  Lapatinib connects receptor-defined kinase inhibition with practical assays for proliferation, cell-cycle arrest, invasion, and angiogenesis. This workflow emphasizes how to interpret activity in HER2-positive models alongside phenotype-first experiments in HER2-negative triple-negative breast cancer systems.

• Capecitabine in Tumor–Stroma-Aware Drug Discovery

  2026-09-11

  Capecitabine is more than a 5-fluorouracil prodrug: its translational value depends on where enzymatic activation occurs and how tumor–stroma interactions reshape response. By connecting Capecitabine biology with patient-derived gastric cancer assembloids, this article outlines a more rigorous strategy for preclinical oncology research, biomarker development, and tumor-targeted drug delivery.

• HyperFluor 488 for Variant-Aware IgG Assays

  2026-09-10

  Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports variant-aware human IgG detection without confusing binding signals with neutralization. This guide translates RQ3025 vaccine findings into practical assay design, controls, and readout decisions.

8525 records 1/569 page Next 12345 下5页 Last page